Angiotensin II Type 1 Receptor–Mediated Inflammation Is Required for Choroidal Neovascularization

Abstract

AT1-R-mediated inflammation plays a pivotal role in the development of CNV, indicating the possibility of AT1-R blockade as a novel therapeutic strategy to inhibit CNV.